Pharmaceutical - Antibiotics and Infectious diseases, Europe

Filter

Popular Filters

Urgent action needed to address Clostridium difficile infections in Europe

Urgent action needed to address Clostridium difficile infections in Europe

03-12-2014

Urgent action is needed to address the current issues relating to the management of health care-acquired…

Antibiotics and Infectious diseasesEuropeEuropean ParliamentPharmaceuticalPolitics

EMA completes review of polymyxins and issues updated guidance

EMA completes review of polymyxins and issues updated guidance

24-10-2014

The European Medicines Agency has completed its review of polymyxin-based medicines and issued its recommendations…

Antibiotics and Infectious diseasesColistimethateEuropePharmaceuticalRegulation

EMA opens public consultation on proposition to avoid duplicating clinical trials in children

EMA opens public consultation on proposition to avoid duplicating clinical trials in children

24-09-2014

The European Medicines Agency is proposing a new development plan that would avoid the duplication of…

Antibiotics and Infectious diseasesEuropeEuropean Medicines AgencyMedicinePharmaceuticalResearch

Durata out-licenses dalbavancin to Angelini for certain territories

Durata out-licenses dalbavancin to Angelini for certain territories

30-07-2014

USA-based Durata Therapeutics says its Dutch subsidiary entered into a license and supply agreement with…

AngeliniAntibiotics and Infectious diseasesDalvanceDurata TherapeuticsEuropeLicensingPharmaceutical

GlobalData says UK fears over antibiotic resistance is

GlobalData says UK fears over antibiotic resistance is "valid conclusion"

04-07-2014

Earlier this week, UK Prime Minister David Cameron revealed the formation of an independent review panel…

Antibiotics and Infectious diseasesEuropePharmaceuticalResearchUSA

New data shows Astellas’ fidaxomicin is effective as first-line treatment for Clostridium difficile infection

New data shows Astellas’ fidaxomicin is effective as first-line treatment for Clostridium difficile infection

14-05-2014

The European subsidiary of Japanese drug major Astellas Pharma has released data demonstrating that fidaxomicin…

Antibiotics and Infectious diseasesAstellas PharmaBacteriaDifficile infectionEuropefidaxomicinHealth Medical PharmaMedicineMicrobiologyPharmaceuticalResearch

Otsuka wins EU approval for Deltyba in MDR-TB

30-04-2014

Japanese drugmaker Otsuka Pharmaceutical says that the European Commission has granted a marketing authorization…

Antibiotics and Infectious diseasesDeltybaEuropeOtsukaPharmaceuticalRegulation

Joint purchasing of vaccines and medicines becomes a reality in the EU

Joint purchasing of vaccines and medicines becomes a reality in the EU

10-04-2014

The European Commission today approved a Joint Procurement Agreement, which will enable all European…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceuticalVaccines

Huge disparities in antibiotic consumption across European region, new report shows

Huge disparities in antibiotic consumption across European region, new report shows

20-03-2014

There is an almost fourfold difference between the lowest and the highest antibiotic users among 42 countries…

Antibiotics and Infectious diseasesEuropeMarkets & MarketingPharmaceutical

Incidence of TB down in Europe but multidrug-resistance continues

Incidence of TB down in Europe but multidrug-resistance continues

19-03-2014

Across the 53 countries of the World Health Organization European Region, an estimated 353 000 patients…

Antibiotics and Infectious diseasesEuropeHealthcarePharmaceutical

Clinigen plans to launch Vibativ after lifting of EU marketing authorization suspension

Clinigen plans to launch Vibativ after lifting of EU marketing authorization suspension

18-03-2014

UK specialty pharma company the Clinigen Group today announced that the European Commission has ratified…

Antibiotics and Infectious diseasesClinigen GroupEuropeMarkets & MarketingPharmaceuticalRegulationTelavancin for InjectionUKVibativ

Janssen’s Sirturo gets conditional EU approval for multi-resistant TB

Janssen’s Sirturo gets conditional EU approval for multi-resistant TB

10-03-2014

US health care giant Johnson & Johnson’s European subsidiary Janssen-Cilag has been granted conditional…

Antibiotics and Infectious diseasesEuropeJanssen-CilagJohnson & JohnsonPharmaceuticalRegulationSirturo

Joint European program targets novel antibiotic

12-02-2014

More than 30 European universities and companies, led by GlaxoSmithKline and Uppsala University, are…

Antibiotics and Infectious diseasesEuropeMerck & CoPharmaceuticalResearch

Clinigen to provide first access to anti-bacterial Vibativ in Europe

Clinigen to provide first access to anti-bacterial Vibativ in Europe

08-01-2014

UK-based Clinigen Group has announced the initiation of an early access program to provide the anti-bacterial…

Antibiotics and Infectious diseasesClinigen GroupEuropeLicensingPharmaceuticalProductionUKVibativ

Four medicines recommended for approval by EMA/CHMP

Four medicines recommended for approval by EMA/CHMP

22-12-2013

Following regular monthly meeting of the European Medicines Agency’s Committee for Medicinal Products…

AlconAntibiotics and Infectious diseasesComtriqDermatologicalsEuropeGaldermaJanssen-CilagJohnson & JohnsonMirvasoNovartisOncologyOphthalmicsPharmaceuticalRegulationSirturoTMC Pharma Services

Back to top